🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, open label study designed to compare the...
Status
Completed
Location
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino
Start Date
2009-07
Trial ID
NCT01091831
Treatments Being Tested
Without therapy HLH is often fatal, and often rapidly fatal. The treatment ...
Status
Completed
Location
Childhood Cancer Research Unit, Karolinska Hospital
Start Date
2004-01
Trial ID
NCT00426101
Treatments Being Tested
RATIONALE: Diphenhydramine, lorazepam, and dexamethasone may help lessen or...
Status
Terminated
Location
Children's Hospital of Southwest Florida
Start Date
2007-10
Trial ID
NCT00429702
Treatments Being Tested
This study will assess the safety, tolerability, and pharmacokinetics of AZ...
Status
Completed
Location
Research Site
Start Date
2015-12-28
Trial ID
NCT02617277
Primary Objectives: * To evaluate the results of Paclitaxel and pelvic rad...
Status
Completed
Location
M. D. Anderson Cancer Center - Orlando
Start Date
2001-04
Trial ID
NCT00515073
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - Main /ID# 261434
Start Date
2024-05-19
Trial ID
NCT06158841
Treatments Being Tested
The primary objective of this clinical study is to evaluate the efficacy an...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12
Trial ID
NCT07246070
Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin re...
Status
Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-11-11
Trial ID
NCT05476770
This study is for patients with locally advanced pancreatic cancer (cancer ...
Status
Unknown
Location
Columbia University Medical Center
Start Date
2009-12
Trial ID
NCT01065870
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic
Start Date
2010-03
Trial ID
NCT01072773
Treatments Being Tested